ArticleKidney international reports2021

PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis.

Laurence H Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.